Beximco Pharmaceuticals Company Description
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.
The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids.
The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Country | Bangladesh |
Founded | 1976 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 1,122 |
CEO | Iqbal Ahmed |
Contact Details
Address: 19 Dhanmondi R/A Dhaka, 1205 Bangladesh | |
Phone | 880 2 5861 1001 |
Website | beximcopharma.com |
Stock Details
Ticker Symbol | BXP |
Exchange | London Stock Exchange AIM |
Fiscal Year | July - June |
Reporting Currency | BDT |
ISIN Number | US0885792061 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Iqbal Ahmed | Chief Executive Officer |
Mohammad Nawaz | Chief Financial Officer |
S. M. Reza | Chief Operating Officer |